Usana Health Sciences
USNA· Manufacturing· Fiscal year ends in January
No proxy on file names the CEO of Usana Health Sciences.
Executives5
See all- 1Jim H. BrownChief Executive Officer & President (former)FY2025
- 2Walter NootChief Operating OfficerFY2025
- 3Joshua FoukasChief Legal Officer & General CounselFY2025
- 4G. Douglas HekkingChief Financial OfficerFY2024
- 5Brent NeidigChief Commercial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allUsana Health Sciences paid its 4 named executives $8.9M in total in FY2025 (Jan).
| Name | |||
|---|---|---|---|
| Jim H. BrownChief Executive Officer & President (former) | |||
| Walter NootChief Operating Officer | |||
| Joshua FoukasChief Legal Officer & General Counsel | |||
| Brent NeidigChief Commercial Officer | |||
| G. Douglas HekkingChief Financial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Jan) proxy of Usana Health Sciences names 15 peer companies for pay. Among Usana Health Sciences and these peers, CEO pay was 5th highest of 6 and total shareholder return was 5th highest of 6.
5th highest of 6in Usana Health Sciences and its pay peers, FY2025 (Jan) by CEO pay:
5th highest of 6in Usana Health Sciences and its pay peers, FY2025 (Jan) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board3
See all- Frederic J. WinssingerDirector · 9 yr on the boardIndependentAudit, Compensation (Chair), Governance, Risk & Nominating, Sustainability—Paid as an executive
- John T. FlemingDirector · 5 yr on the boardIndependentCompensation, Governance, Risk & Nominating, Sustainability—Paid as an executive
- Xia DingDirector · 4 yr on the boardIndependentAudit, Governance, Risk & Nominating—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 7, 2026 | FY2025 |
| Annual report | 10-K | Mar 16, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 4, 2025 | FY2024 |
| Annual report | 10-K | Mar 12, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 22, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |
